Medical News
HIV
HIV
Join Us in Sharing and Promoting Together TakeMeHome (TTMH)
Tue, 21 Mar 2023 14:00:00 EST
Learn more about Together TakeMeHome (TTMH), a project with the goal of distributing up to 1 million free HIV self-tests over the next five years.
Vital Signs: Progress Toward Eliminating HIV as a Global Public Health Threat Through Scale-Up of Antiretroviral Therapy and Health System Strengthening Supported by the U.S. President's Emergency Plan for AIDS Relief - Worldwide, 2004-2022
Tue, 14 Mar 2023 13:37:00 EST
By 2022, approximately 20 million persons with HIV infection in 54 countries received PEPFAR-supported ART (62% CDC-supported); this number represents an increase of 300-fold from 66,6550 in 2004. During 2015-2022, viral load suppression rates increased from 80% to 95% among those who received testing.
Public Health Response to Clusters of Rapid HIV Transmission Among Hispanic or Latino Gay, Bisexual, and Other Men Who Have Sex with Men - Metropolitan Atlanta, Georgia, 2021-2022
Mon, 13 Mar 2023 11:00:00 EST
In 2021, molecular HIV analysis in Georgia identified clusters of rapid HIV transmission among Hispanic or Latino (Hispanic) gay, bisexual, and other men who have sex with men (MSM) in metropolitan Atlanta. A multicomponent investigation identified factors that might limit access to HIV services, including language barriers, immigration- and deportation-related concerns, and sexuality-related cultural norms. Health departments, providers, and community-based organizations collaborated to address these barriers.
Social Determinants of Health among Adults with Diagnosed HIV Infection in the United States and Puerto Rico, 2020
Thu, 09 Mar 2023 11:58:00 EDT
This report examines census tract-level social determinants of health (SDOH) among adults with diagnosed HIV infection in 2020 in the 50 states, the District of Columbia, and Puerto Rico. Data are presented for diagnoses of HIV infection, linkage to care, and viral suppression through 2020 among persons aged 18 years and older by 5 SDOH indicators and selected characteristics that include sex, age, race/ethnicity, and transmission category. This report also addresses health disparities and factors for special consideration in addressing health disparities.
Notice of Funding Opportunity PS23-001: Increasing PrEP Use Among Black Cisgender Women in the United States (HerPrEP)
Tue, 07 Mar 2023 09:15:00 EDT
The purpose of this NOFO is to support an implementation research study to evaluate strategies to increase HIV pre-exposure prophylaxis (PrEP) use among Black/African American (Black) cisgender women in the United States. The recipient should implement and evaluate strategies in healthcare clinics to increase PrEP provision by healthcare providers and PrEP use by Black cisgender women.
Notice of Funding Opportunity PS23-002: Enhancing Telehealth Strategies to Support Retention and Adherence to Antiretroviral Therapy (ART)
Wed, 01 Feb 2023 10:25:00 EDT
This Notice of Funding Opportunity will support research on evidence of effectiveness of TeleART by implementing a hybrid effectiveness-implementation research study.
Notice of Funding Opportunity PS23-003: Exploring Preferences for Long-Acting Antiretroviral Therapies (LA-ART) in a Community-Based Sample of Priority Populations Living with HIV Who are Disproportionately Affected
Wed, 01 Feb 2023 10:23:00 EDT
This Notice of Funding Opportunity will support qualitative research to inform strategies to strengthen uptake and adherence to ART and reduce existing disparities in HIV viral suppression among cis-gender Black women with HIV (CgBWH).
Dear Colleague: February 7 is National Black HIV/AIDS Awareness Day (NBHAAD)
Wed, 01 Feb 2023 10:00:00 EDT
Read this year's NBHAAD Dear Colleague Letter to learn how you can help us raise awareness about HIV testing, prevention, and treatment for African American people.
Notice of Funding Opportunity PS-23-005: Expanding Rapid Initiation of Antiretroviral Therapy in Non-traditional Settings: Emergency Department
Thu, 26 Jan 2023 14:49:00 EDT
The purpose of this NOFO is to support research to investigate how to deploy and optimize rapid ART delivery in emergency departments that are currently routinely screening for HIV infection. Emergency departments offer a unique opportunity to immediately engage with newly diagnosed patients to initiate ART and provide linkage to an HIV provider in the community. This research may help determine whether HIV testing and rapid ART in EDs can improve engagement, linkage and retention in care, and viral suppression among newly diagnosed people with HIV (PWH), as well as those previously diagnosed with HIV but who are not engaged in care.
Notice of Funding Opportunity PS-23-004: Long-Acting Injectables for the Treatment of HIV in Non-Clinic Community-Based Settings
Thu, 26 Jan 2023 14:48:00 EDT
The purpose of this NOFO is to support research on long-acting injectable (LAI) antiretroviral therapy (ART) by implementing LAI-ART administration in non-clinic settings. Utilizing an innovative strategy of LAI-ART administration in non-clinic-based settings to decentralize the delivery of LAI-ART for HIV treatment will expand treatment opportunities. Recipients of this NOFO will conduct qualitative and quantitative research resulting in data describing real-world LAI-ART use in an era of multiple HIV treatment modalities.
Notice of Funding Opportunity PS-23-006: Identifying and Addressing Historical and Structural Drivers of Medical Mistrust among Hispanic/Latino Gay, Bisexual and Other Men Who Have Sex with Men (HLMSM) for HIV Prevention. Applications are due on February 23, 2023.
Tue, 24 Jan 2023 11:04:00 EDT
This new funding opportunity announcement is an opportunity to (1) identify drivers of medical mistrust (MM) in Hispanic/Latino (H/L) populations in the United States with special attention to gay, bisexual and other men who have sex with men (HLMSM), and (2) address this social determinant of health by implementing and evaluating multilevel interventions in selected sites. Describing trauma from diverse H/L descent will lead to culturally centered and trustworthy multilevel interventions that will in turn decrease health disparities.
February 7 is National Black HIV/AIDS Awareness Day (NBHAAD)
Mon, 23 Jan 2023 11:48:00 EDT
NBHAAD is a day to increase awareness about HIV among African Americans and encourage people to get involved in prevention efforts, get tested, get treatment if they have HIV, and use prevention tools such as pre-exposure prophylaxis (PrEP) or condoms if they do not have HIV. It is also a day to work toward reducing HIV-related stigma.
HIV Surveillance Data Tables: Core Indicators for Monitoring the Ending the HIV Epidemic in the U.S. initiative
Thu, 15 Dec 2022 11:57:00 EDT
The tables included in this report provide preliminary data on HIV diagnoses and linkage to HIV medical care reported to CDC as of September 2022 for the years 2021 and 2022, and data on preexposure prophylaxis (PrEP) coverage for the years 2019, 2020, 2021, and 2022 (preliminary).
HIV Mortality 2020 Slide Set
Mon, 12 Dec 2022 11:21:00 EDT
The 2020 HIV Mortality Slide Set outlines trends in mortality in the United States, focusing on deaths attributed to HIV disease. Among persons with HIV disease as the underlying cause of death in 2020, males, Black and African American persons, residents of the South, and persons aged 45 years and older were the most impacted.
Dear Colleague: CDC Observes World AIDS Day
Thu, 01 Dec 2022 14:01:00 EDT
World AIDS Day observed each year on December 1, is an opportunity for people worldwide to unite in the fight against HIV, show their support for people living with HIV, and remember those who have died.
Issue Brief: The Role of Housing in Ending the HIV Epidemic
Thu, 01 Dec 2022 11:40:00 EDT
This issue brief highlighting how CDC, other federal agencies & community partners are collaborating to equitably address housing & HIV care needs through funding, program implementation & research
World AIDS Day Toolkit
Wed, 02 Nov 2022 09:56:00 EST
Find and share social media posts to raise HIV awareness among people worldwide and encourage them to get tested and know their prevention options.
DHP Strategic Plan Supplement 2022-2025
Thu, 13 Oct 2022 21:41:00 EST
DHP developed refreshed priorities to support the existing 2017-2020 Strategic Plan and to better align division priorities with the 2022-2025 National HIV/AIDS Strategy (NHAS) and the Ending the HIV Epidemic in the United States (EHE) initiative. The strategies outlined in the supplement will further enable DHP to deliver on the strategic goals and objectives from the existing 2017-2020 Strategic Plan over the next three years
October 15 is National Latinx AIDS Awareness Day (NLAAD)
Thu, 13 Oct 2022 14:00:00 EST
This NLAAD, join us in celebrating the progress in HIV prevention among Hispanic/Latino people.
HIV Stigma and Health Care Discrimination Experienced by Hispanic or Latino Persons with HIV - United States, 2018-2020
Thu, 13 Oct 2022 13:43:00 EST
Among 1,969 persons with monkeypox in eight U.S. jurisdictions, 38% had HIV infection, and 41% had an STI in the preceding year. Among persons with monkeypox, hospitalization was more common among persons with HIV infection than persons without HIV infection.
HIV Infographics Library
Thu, 29 Sep 2022 13:45:00 EST
CDC's new HIV infographics library has more than 200 charts on HIV. Download and share them to help raise awareness about HIV prevention and treatment.
Core Indicators for Monitoring the Ending the HIV Epidemic Initiative (Preliminary Data): National HIV Surveillance System Data Reported through June 2022; and Preexposure Prophylaxis (PrEP) Data Reported through March 2022
Thu, 29 Sep 2022 11:54:00 EST
This report is a quarterly update of data on 3 indicators for monitoring the Ending the HIV Epidemic in the U.S. initiative. Data on HIV diagnoses and linkage to HIV medical care are provided through June 2022. Data on PrEP coverage is provided through March 2022.
Dear Colleague: September 27 is National Gay Men's HIV/AIDS Awareness Day (NGMHAAD)
Thu, 22 Sep 2022 14:00:00 EST
September 27 is National Gay Men's HIV/AIDS Awareness Day. Help raise awareness about HIV testing, prevention, and treatment among gay and bisexual men.
2020 Partner Services Annual Report
Fri, 16 Sep 2022 10:17:00 EST
This report summarizes the 2020 client-level partner services data from 53 of the 60 CDC-funded state and local health departments in the United States, Puerto Rico, and the U.S. Virgin Islands.
HIV and Sexually Transmitted Infections Among Persons with Monkeypox - Eight U.S. Jurisdictions, May 17-July 22, 2022
Fri, 09 Sep 2022 15:00:00 EST
Among 1,969 persons with monkeypox in eight U.S. jurisdictions, 38% had HIV infection, and 41% had an STI in the preceding year. Among persons with monkeypox, hospitalization was more common among persons with HIV infection than persons without HIV infection.
Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data United States and 6 Dependent Areas, 2020
Wed, 31 Aug 2022 09:39:00 EST
The report "Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data United States and 6 Dependent Areas, 2020" has been updated to include five new quality of life indicators (Table 10) announced with the release of the National HIV/AIDS Strategy (NHAS) Federal Implementation Plan. This updated report, originally released in May 2022, was re-published on the CDC website on August 26, 2022.
Modeling the Impact of Sexual Networks in the Transmission of Monkeypox virus Among Gay, Bisexual, and Other Men Who Have Sex With Men - United States, 2022
Tue, 30 Aug 2022 11:06:00 EST
The 2022 monkeypox outbreak is associated with sexual and intimate contact. Survey data suggest that gay, bisexual, and other men who have sex with men (MSM), who have been disproportionately affected, are reducing one-time partnerships.
Strategies Adopted by Gay, Bisexual, and Other Men Who Have Sex with Men to Prevent Monkeypox virus Transmission - United States, August 2022
Tue, 30 Aug 2022 11:04:00 EST
In a recent survey of gay, bisexual, and other men who have sex with men, approximately one half reported reducing their number of sex partners, one-time sexual encounters, and use of dating apps because of the monkeypox outbreak. Receipt of vaccine to protect against monkeypox varied by race, ethnicity, and geography.
Issue Brief: Status-Neutral HIV Care and Service Delivery
Tue, 23 Aug 2022 15:55:00 EST
This issue briefs describes CDC's approach to status neutral HIV care.
Core Indicators for Monitoring the Ending the HIV Epidemic in the United States Initiative
Tue, 09 Aug 2022 12:01:00 EST
This set of HIV Surveillance Data Tables provides the most current data on core indicators for monitoring the Ending the HIV Epidemic in the United States Initiative. Data on HIV diagnoses and linkage to HIV medical care reported through the National HIV Surveillance System through March 2022, and PrEP data reported through December 2021 are included in this release.
Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection - United States, August 2022
Fri, 05 Aug 2022 13:19:00 EST
A multinational monkeypox outbreak disproportionately affecting men who have sex with men, including persons with HIV infection, is ongoing worldwide.
Integrated HIV Surveillance & Prevention Programs for Health Departments (PS18-1802): Monitoring and Evaluation Report, 2020
Thu, 28 Jul 2022 07:01:00 EST
CDC's National HIV Prevention Program Monitoring and Evaluation (NHM&E) data are presented that monitor the impact of CDC-funded HIV testing efforts and programmatic activities, and progress toward achieving the national HIV prevention goals from January through December 2020
Behavioral and Clinical Characteristics of Persons with Diagnosed HIV Infection Medical Monitoring Project, United States 2020 Cycle (June 2020-May 2021)
Tue, 12 Jul 2022 13:05:00 EST
These are published data from the 2020 cycle (June 2020-May 2021) of the CDC Medical Monitoring Project, or MMP. The MMP is a surveillance system designed to learn more about the experiences and needs of people with HIV. The report provides information on behavioral and clinical outcomes affecting the risk of HIV transmission, morbidity, and mortality that are critical for achieving national HIV prevention goals.
EHE in Action: Telehealth in Kentucky
Thu, 07 Jul 2022 08:59:00 EST
With support from the EHR initiative, two organizations in rural Kentucky are using successful telehealth models to reach people with the care they need to stay healthy.
EHE in Action: HIV Self-Testing Success Story
Thu, 07 Jul 2022 08:58:00 EST
With support from the Ending the HIV Epidemic initiative and Minority HIV/AIDS Fund, CDC launched a new project to deliver 100,000 #HIV self-tests to key groups in communities heavily affected by HIV.
Monitoring EHE Progress
Thu, 07 Jul 2022 08:57:00 EST
This digital-first resource provides a user-friendly summary of CDC's HIV data organized by the EHE pillars: Diagnose, Treat, Prevent, and Respond. This data is used to track the nation's progress towards ending the HIV epidemic.
HIV Testing Before and During the COVID-19 Pandemic - United States, 2019-2020
Tue, 28 Jun 2022 09:13:00 EST
HIV testing is the first step in accessing HIV prevention and care services. The COVID-19 pandemic disrupted health care delivery and might have affected HIV testing, which is critical to ending the HIV epidemic in the United States.
Dear Colleague: National HIV Testing Day is June 27!
Fri, 24 Jun 2022 12:57:00 EST
Read about trends in HIV testing and CDC's ongoing commitment to expanding HIV testing efforts.
Dear Colleague: HIV Surveillance Reports
Tue, 24 May 2022 14:02:00 EST
This Dear Colleague letter announces the publication of two new HIV surveillance reports and an AtlasPlus update. The COVID-19 pandemic in the United States led to disruptions in HIV testing services and access to clinical services throughout 2020. This disruption resulted in a steep, single-year decline in HIV diagnoses that is mostly attributed to declines in testing caused by less frequent visits to health centers, reduced outreach services, and shifting of public health staff to COVID-19 response activities. Given these disruptions, data for 2020 should be interpreted with caution.
Diagnoses of HIV infection in the United States and dependent areas, 2020
Tue, 24 May 2022 12:04:00 EST
The annual surveillance report summarizes information about diagnosed HIV infection in the United States and dependent areas. HIV surveillance data are used by CDC and their public health partners in other federal agencies, health departments, nonprofit organizations, academic institutions, and the public to help focus prevention efforts; plan services; allocate resources; develop policy; detect, monitor, and intervene in HIV clusters; and monitor trends in HIV infection.
Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data-United States and 6 Dependent Areas, 2020
Tue, 24 May 2022 12:03:00 EST
This report complements the HIV Surveillance Report and presents the results of focused analyses of National HIV Surveillance System (NHSS) data to measure progress toward achieving national HIV prevention and care goals. Data for persons aged ≥13 years with diagnosed HIV are presented for linkage to care, receipt of care, viral suppression, stage 3 (AIDS) classifications at HIV diagnosis, deaths, and survival. Also included are data on perinatally acquired HIV infection in the U.S. and preexposure prophylaxis (PrEP) data (prescriptions, indications, and coverage) for persons aged ≥16 years.
HIV Surveillance Data Tables: Core Indicators for Monitoring the Ending the HIV Epidemic in the U.S. Initiative, NHSS Data through December 2021 and PrEP data through September 2021
Tue, 24 May 2022 12:02:00 EST
Report includes the latest data on the core indicators for monitoring the Ending the HIV Epidemic in the U.S. initiative.
HIV Surveillance Slide Set: HIV Infection, Stage 3 (AIDS)
Tue, 24 May 2022 12:01:00 EST
HIV surveillance slide set that presents data on trends in HIV infection stage 3 (AIDS) classifications.
Factors Associated with Use of HIV Prevention and Health Care Among Transgender Women - Seven Urban Areas, 2019-2020
Fri, 20 May 2022 16:00:00 EST
During 2019-2020, 38% of transgender women surveyed in seven major U.S. cities reported receiving a previous positive HIV test result. Low income (44%), experiencing homelessness (39%), and severe food insecurity (40%) were common and associated with lower likelihood of receipt of HIV prevention and health care; having a health care provider with whom the participant is comfortable was positively associated with receiving those services.
HIV in the United States by Region
Tue, 03 May 2022 11:10:00 EST
This updated web content provides information and data about HIV in the US Regions.
Issue Brief: HIV and Transgender Communities
Fri, 22 Apr 2022 15:00:00 EST
This issue brief describes what can be done to address key gaps in HIV prevention and care for transgender people.
HIV in the US by Race/Ethnicity
Thu, 14 Apr 2022 12:06:00 EST
This new web content provides information and statistical data about HIV in the United States by race/ethnicity.
Dear Colleague: Transgender HIV Testing Day
Thu, 14 Apr 2022 09:58:00 EST
National Transgender HIV Testing Day is observed each year on April 18. This day is an opportunity to focus on HIV testing, prevention, and treatment among transgender people. It encourages local testing events and testing campaigns to increase HIV status awareness in transgender populations.
HIV and Transgender People
Thu, 14 Apr 2022 09:02:00 EST
This updated web page provides information and statistical data about HIV and transgender people, including a fact sheet that visually displays this information.
HIV in the US by Age
Fri, 08 Apr 2022 11:39:00 EST
This new web content provides information and statistical data about HIV in the United States by age group.
Dear Colleague: PS 22-2203 Comprehensive High-Impact HIV Prevention Programs for Young Men of Color Who have Sex with Men and Young Transgender Persons of Color
Fri, 01 Apr 2022 12:59:00 EST
the Centers for Disease Control and Prevention (CDC) awarded funds to 36 community-based organizations (CBOs) under the program PS22-2203: Comprehensive High-Impact HIV Prevention Programs for Young Men of Color Who have Sex with Men and Young Transgender Persons of Color. Through this funding opportunity, CBOs will develop and implement high-impact HIV prevention programs for young men of color who have sex with men, young transgender persons of color, and their partners regardless of age, gender, and race/ethnicity.
Integrated Guidance for Developing Epidemiologic Profiles: HIV Prevention and Ryan White CARE Act Community Planning (Updated March 2022)
Thu, 17 Mar 2022 08:57:00 EST
The Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) developed the Integrated Guidance for Developing Epidemiologic Profiles: HIV Prevention and Ryan White HIV/AIDS Program Planning to assist with compiling and interpreting HIV prevention, surveillance, and care data for state, territorial, or local HIV epidemiologic profiles. The document provides one set of guidance to help profile writers develop integrated epidemiologic profiles and to advise them how to interpret epidemiologic data in ways that are consistent with, and useful in, meeting the planning and evaluation needs of both HIV prevention and care programs.
Today is National Women and Girls HIV/AIDS Awareness Day (NWGHAAD)
Thu, 10 Mar 2022 17:25:00 EDT
March 10 is National Women and Girls HIV/AIDS Awareness Day (NWGHAAD), a time when organizations and communities across the United States come together to offer support, encourage discussion, and teach women and girls about the prevention of HIV, the importance of getting tested, and how to live with and manage HIV infection.
HIV and Women Web Content and Fact Sheet
Wed, 09 Mar 2022 17:26:00 EDT
This updated web content provides information and data about HIV among women in the US and dependent areas.
HIV Surveillance Report: Social Determinants of Health among Adults with Diagnosed HIV Infection, 2019
Wed, 09 Mar 2022 10:59:00 EDT
This report examines census tract-level social determinants of health (SDH) among adults with diagnosed HIV infection in 2019 in the 50 states, the District of Columbia, and Puerto Rico. Data are presented for diagnoses of HIV infection, linkage to care, and viral suppression through 2019 among persons aged 18 years and older by 5 SDH indicators and selected characteristics that include sex, age, race/ethnicity, and transmission category. This report also addresses health disparities and factors for special consideration in addressing health disparities.
HIV Prevention and Care Priorities - Regional Community Engagement Town Halls
Wed, 09 Mar 2022 09:03:00 EDT
The Division of HIV Prevention (DHP) is hosting our first HIV Prevention and Care Priorities - Regional Virtual Community Engagement Town Hall on, March 24 , 2022 10:30 - 12:00 p.m. EST with HHS Region 3. The Town Hall will provide a venue for discussion and collaboration focused on barriers to and opportunities for improving HIV diagnosis, treatment, prevention, and outbreak response.
Issue Brief: The Role of HIV Self-Testing in Ending the HIV Epidemic
Fri, 04 Mar 2022 10:27:00 EDT
HIV self-testing programs offer an innovative way to bridge gaps in access to HIV testing. To ensure that HIV self-testing services are available to all who could benefit from them, CDC conducts a range of activities to support and expand the implementation of self-testing.
Cluster Detection and Response FAQs
Wed, 02 Mar 2022 11:39:00 EDT
New web page with FAQs about HIV Cluster Detection and Response.
Dear Colleague: CDC Guideline modernization
Wed, 23 Feb 2022 13:22:00 EDT
CDC is modernizing its approach to clinical guidelines to reduce the time it takes to apply guidance to patient care and ensure that clinicians and patients can make informed decisions guided by the best available evidence to achieve optimal health outcomes.
Notice of Funding Opportunity PS22-2211: Enhanced Surveillance of Persons with Early and Late HIV Diagnosis
Wed, 23 Feb 2022 07:17:00 EDT
This NOFO is a re-announcement of PS22-2202. The purpose of this NOFO is to improve understanding of barriers and gaps in HIV prevention services that may lead to continued HIV transmission or delayed diagnosis of HIV. This NOFO will support enhanced surveillance of people diagnosed with HIV during the earliest and latest stages of infection (i.e., stages 0 and 3, respectively) to understand recent experiences with HIV prevention and testing services, as well as the system- and individual-level barriers that led to these failures in early diagnosis and prevention. Recipients of this NOFO will identify, locate, and recruit all persons diagnosed in the past year with stage 0 or stage 3 infection in their jurisdiction for participation in behavioral interviews conducted by a CDC contractor.
HIV and African American People Web Content and Fact Sheet
Thu, 10 Feb 2022 09:47:00 EDT
This web page provides updated information and statistical data about HIV and Black/African American people, including a fact sheet that visually displays this information.
Dear Colleague: National Black HIV/AIDS Awareness Day (NBHAAD)
Mon, 07 Feb 2022 09:59:00 EDT
NBHAAD is a day to increase awareness about HIV among African Americans and encourage people to get involved in prevention efforts, get tested, get treatment if they have HIV, and use prevention tools such as pre-exposure prophylaxis (PrEP) or condoms if they do not have HIV. It is also a day to work toward reducing HIV-related stigma.
HIV Surveillance Supplemental Surveillance Report: HIV and AIDS Data through December 2019 Provided for the Ryan White HIV/AIDS Program, for Fiscal Year 2021
Thu, 27 Jan 2022 11:46:00 EDT
Reporting of data tables provided by CDC to HRSA for Ryan White HIV/AIDS Program funding for fiscal year 2021.
CDC-Funded HIV Testing in the United States, Puerto Rico, and the U.S. Virgin Islands, 2020
Thu, 13 Jan 2022 15:21:00 EDT
This report describes the demographics of persons tested, newly diagnosed with HIV, and linked to HIV medical care in the United States, Puerto Rico, and U.S. Virgin Islands in 2020. Data presented in this report include HIV test-level data from 60 state and local health departments and 100 community-based organizations reported to CDC through EvaluationWeb® as of September 15, 2021.
HIV and African American Gay and Bisexual Men Web Content and Fact Sheet
Tue, 11 Jan 2022 14:18:00 EDT
This updated web content provides information and statistical data about HIV among African American gay and bisexual men, including a fact sheet that visually displays this information.
2019 HIV Mortality
Mon, 03 Jan 2022 08:21:00 EDT
The 2019 HIV Mortality Slide Set outlines mortality data from 2019 among persons with HIV and deaths among persons with HIV as an underlying cause of death.
EHE Core Indicators HIV Surveillance Data Tables, NHSS September 2021 and PrEP June 2021
Wed, 15 Dec 2021 11:58:00 EDT
Update on data for monitoring the Ending the HIV Epidemic in the United States initiative reported through CDC through September 2021 and PrEP data through June 2021. Data on HIV diagnoses, linkage to HIV medical care, and PrEP are provided.
Dear Colleague Letter: Updated Clinical Practice Guideline for Preexposure Prophylaxis for HIV Prevention and Clinical Providers Supplement
Wed, 08 Dec 2021 13:00:00 EDT
The updated guideline and supplement reflect the latest science and are intended to help physicians effectively prescribe all FDA-approved pre-exposure prophylaxis (PrEP) medications to patients and increase PrEP use among all people who could benefit. The overall goals of the revisions are to update existing guidance using the current evidence base, incorporate recent and potential FDA actions on PrEP medications, clarify specific aspects of clinical care, and improve usability and increase implementation of the guideline.
Dear Colleague: CDC Observes World AIDS Day
Wed, 01 Dec 2021 11:21:00 EDT
World AIDS Day observed each year on December 1, is an opportunity for people worldwide to unite in the fight against HIV, show their support for people living with HIV, and remember those who have died.
Vital Signs: HIV Infection, Diagnosis, Treatment, and Prevention Among Gay, Bisexual, and Other Men Who Have Sex with Men - United States, 2010-2019
Tue, 30 Nov 2021 18:00:00 EDT
Gay, bisexual, and other men who have sex with men (MSM) are disproportionately affected by HIV.
Racial, Ethnic, and Gender Disparities in Awareness of Preexposure Prophylaxis Among HIV-Negative Heterosexually Active Adults at Increased Risk for HIV Infection - 23 Urban Areas, United States, 2019
Mon, 29 Nov 2021 12:00:00 EDT
Heterosexual sex accounts for 23% of new HIV diagnoses annually. Heterosexual adults are underrepresented in preexposure prophylaxis (PrEP) research and campaigns. Increasing PrEP awareness and use in this population is needed to prevent HIV transmission and end the HIV epidemic in the United States.
World AIDS Day - December 1, 2021
Tue, 23 Nov 2021 09:58:00 EDT
World AIDS Day, observed annually on December 1, draws attention to the status of the human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) epidemic.
Partner Services Annual Report, 2019
Mon, 25 Oct 2021 09:30:00 EST
This report summarizes the 2019 client-level partner services data from 52 of the 60 CDC-funded state and local health departments in the United States, Puerto Rico, and the U.S. Virgin Islands.
Cluster Detection and Response Community Spotlights - Stories from the Field
Fri, 22 Oct 2021 17:15:00 EST
Community Spotlights featuring cluster detection and response efforts that brought communities together and resulted in better tailored HIV prevention and care activities.
Updated Cluster Detection and Response pages
Fri, 22 Oct 2021 17:14:00 EST
An overview of what HIV Cluster Detection and Response is, who it benefits, and why it's a critical tool in ending the HIV epidemic.
Core indicators for monitoring the Ending the HIV Epidemic initiative (preliminary data)
Wed, 20 Oct 2021 11:57:00 EST
The tables included in this report provide preliminary data on HIV diagnoses and linkage to HIV medical care reported to CDC as of June 2021 for the years 2020 and 2021, and data on preexposure prophylaxis (PrEP) coverage for the years 2019, 2020, and 2021 (preliminary). Data for the 3 indicators are provided at the national, state, and county levels (EHE Phase I jurisdictions only).
Updated: HIV and Hispanic/Latino People
Fri, 15 Oct 2021 16:10:00 EST
Get the latest data on HIV among Hispanic/Latino people and find out how CDC is making a difference.
Updated: HIV and Hispanic/Latino Gay and Bisexual Men
Fri, 15 Oct 2021 16:07:00 EST
Get the latest data on HIV among Hispanic/Latino gay and bisexual men and find out how CDC is making a difference.
Dear Colleague: National Latinx AIDS Awareness Day (NLAAD)
Thu, 14 Oct 2021 16:09:00 EST
October 15, 2021 is National Latinx AIDS Awareness Day, a day to focus on preventing HIV among Hispanics/Latinos and helping those living with HIV stay healthy.
Notice of Funding Opportunity PS22-2202: Enhanced Surveillance of Persons with Early and Late HIV Diagnosis
Fri, 08 Oct 2021 15:03:00 EST
This NOFO will support identification and recruitment of adults with recent HIV diagnoses at stage 0 and stage 3 to improve understanding of barriers and gaps associated with new infection and late diagnosis in the era of multiple testing modalities and prevention options such as PrEP.
HIV Preexposure Prophylaxis Awareness and Referral to Providers Among Hispanic/Latino Persons - United States, 2019
Thu, 07 Oct 2021 15:21:00 EST
Hispanic or Latino (Hispanic) persons are disproportionately affected by HIV. Preexposure prophylaxis (PrEP) is an effective strategy to prevent HIV infection.
New National Latinx AIDS Awareness Day Resources
Tue, 05 Oct 2021 14:45:00 EST
The National Latinx AIDS Awareness Day toolkit has been updated! Please be sure to visit the site to download the latest content and graphics for use in your NLAAD efforts.
Dear Colleague: Dear Colleague: Introducing the New Division of HIV Prevention Organizational Structure
Fri, 01 Oct 2021 15:40:00 EST
The new organizational structure is more fit-for-purpose and better positions DHP to end the HIV Epidemic.
Increasing Access to HIV Testing Through Direct-to-Consumer HIV Self-Test Distribution - United States, March 31, 2020-March
Fri, 24 Sep 2021 14:28:00 EST
Gay, bisexual, and other men who have sex with men (MSM) should be tested for HIV at least annually. Major disruptions to HIV testing services occurred during the COVID-19 pandemic.
Dear Colleague: September 27 is National Gay Men's HIV/AIDS Awareness Day (NGMHAAD)
Fri, 24 Sep 2021 09:00:00 EST
September 27 is National Gay Men's HIV/AIDS Awareness Day. Find out what you can do to help reduce the toll of HIV among gay and bisexual men.
Notice of Funding Opportunity Announcement PS22-2203: Comprehensive High-Impact HIV Prevention Programs for Young Men of Color Who have Sex with Men and Young Transgender Persons of Color
Thu, 23 Sep 2021 07:45:00 EST
The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year 2022 funds for a cooperative agreement program for community-based organizations (CBOs) to develop and implement high-impact human immunodeficiency virus (HIV) prevention programs.
HIV and Gay and Bisexual Men Web Content and Fact Sheet
Thu, 16 Sep 2021 14:01:00 EST
This web content provides information and statistical data about HIV among gay and bisexual men, including a fact sheet that visually displays this information.
Promote National HIV/AIDS and Aging Awareness Day (September 18)
Thu, 09 Sep 2021 09:30:00 EST
Use these social media posts to raise awareness of HIV, address stigma and other barriers to care, and encourage older adults to get tested and know their status.
Behavioral and Clinical Characteristics of Persons with Diagnosed HIV Infection Medical Monitoring Project, United States 2019 Cycle (June 2019-May 2020)
Thu, 05 Aug 2021 09:15:00 EST
These are published data from the 2019 cycle (June 2019-May 2020) of the CDC Medical Monitoring Project, or MMP. The MMP is a surveillance system designed to learn more about the experiences and needs of people with HIV. The report provides information on behavioral and clinical outcomes affecting the risk of HIV transmission, morbidity, and mortality that are critical for achieving national HIV prevention goals.
A Summary of HIV Self-Testing Program Models and Lessons Learned
Fri, 30 Jul 2021 16:20:00 EST
Today, the Centers for Disease Control and Prevention (CDC) published data from the 2019 cycle (June 2019-May 2020) of the Medical Monitoring Project (MMP). The format of the report is now available for the first time in a digital first format, allowing for the report to be viewed easily on a number of digital devices. There are visuals embedded throughout the summary of the report to make the information presented easier to understand and use for our state and local public health partners.
Dear Colleague: Ending the HIV Epidemic in the U.S. Year Two Funding Awards Issued
Tue, 27 Jul 2021 13:22:00 EST
This dear Colleague Letter announces the second major round of CDC funding delivered to state and local health departments as part of the EHE initiative.
Core Indicators for Monitoring the Ending the HIV Epidemic Initiative (Preliminary Data): National HIV Surveillance System Data Reported through March 2021; and Preexposure Prophylaxis (PrEP) Data Reported through December 2020
Thu, 15 Jul 2021 12:00:00 EST
Data are presented for diagnoses of HIV infection reported to CDC through March 2021 and preexposure prophylaxis (PrEP) data reported through December 2020.
HIV Criminalization and EHE
Tue, 22 Jun 2021 11:36:00 EST
To end the HIV epidemic, public health, criminal justice, and legislative systems must work together to ensure that laws protect the community, are evidence-based and just, and support public health efforts.
Dear Colleague: Reflections on 40 Years of HIV
Wed, 09 Jun 2021 16:15:00 EST
June 5, 2021 marks 40 years since the first official reporting, in CDC's Morbidity and Mortality Weekly Report (MMWR), of five cases describing what later became known as Acquired Immune Deficiency Syndrome (AIDS) and what is now HIV Stage III. On this 40th anniversary, we remember the more than 32 million people who have died from HIV worldwide since the start of the global epidemic, and the 38 million people currently living with HIV.
Dear Colleague: CDC Releases New HIV Surveillance and Supplemental Surveillance Reports
Thu, 27 May 2021 16:42:00 EST
Today, the Centers for Disease Control and Prevention (CDC) published three new reports using HIV surveillance data: Estimated HIV Incidence and Prevalence in the United States, 2015-2019; Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data-United States and 6 Dependent Areas, 2019; and Diagnoses of HIV Infection in the United States and Dependent Areas, 2019. To improve data interpretation and utility, these reports all feature data from the same timeframe: 2015-2019.
Diagnoses of HIV Infection in the United States and Dependent Areas, 2019
Thu, 27 May 2021 12:03:00 EST
The annual surveillance report, published by CDC, summarizes information about diagnosed HIV infection in the United States and dependent areas. HIV surveillance data are used by CDC's public health partners in other federal agencies, health departments, nonprofit organizations, academic institutions, and the general public to help focus prevention efforts; plan services; allocate resources; develop policy; detect, monitor, and intervene in HIV clusters; and monitor trends in HIV infection.
Estimated HIV Incidence and Prevalence in the United States, 2015-2019
Thu, 27 May 2021 12:02:00 EST
This report examines estimates of (1) HIV incidence, (2) prevalence (persons living with diagnosed or undiagnosed HIV infection), and (3) percentage of diagnosed infections among persons living with HIV (percentage of persons living with HIV who are aware of their infection) in the 50 states, the District of Columbia, and Puerto Rico for persons aged greater than or equal to 13 years. Numbers of persons aged greater than or equal to 13 years living with diagnosed infection are reported numbers, not estimates. These numbers are based on diagnosed cases with vital status information reported to CDC through December 2020. Prevalence estimates for the year 2019 are preliminary and based on deaths reported to CDC through December 2020.
Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data-United States and 6 Dependent Areas, 2019
Thu, 27 May 2021 12:01:00 EST
This report complements the HIV Surveillance Report and presents the results of focused analyses of National HIV Surveillance System (NHSS) data to measure progress toward achieving national goals. Diagnoses of HIV infection, linkage to care, receipt of care, retention in care, and viral suppression are presented from jurisdictions that reported complete CD4 and viral load laboratory results to CDC.
Estimated HIV Incidence and Prevalence in the United States, 2010-2019
Thu, 27 May 2021 12:01:00 EST
This slide series presents estimated incidence and prevalence HIV surveillance data for the United States and Puerto Rico.
To view other topics, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Complete Product Information.
